Skip to content

Ironwood Pharmaceuticals IRWD Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$104.45M+297%$26.29M-7.9%$28.55M+462%-$7.89M+75.6%-$32.34M-3,775%
$1.85M-1.9%$1.88M-1.3%$1.91M-1.7%$1.94M-2.0%$1.98M-1.7%
$15.61M-9.5%$17.25M-4.1%$17.99M-20.8%$22.71M-15.1%$26.76M-10.4%
$78.52M-24.2%
$35K0.0%$35K-28.6%$49K-53.3%$105K-26.1%
-$35K0.0%-$35K+28.6%-$49K+53.3%-$105K+26.1%
$216K+101%-$14.79M+64.7%-$41.95M+54.1%-$91.41M+14.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Ironwood Pharmaceuticals generate?
Ironwood Pharmaceuticals (IRWD) generated $147.2M in operating cash flow over the trailing twelve months.
Where does Ironwood Pharmaceuticals's cash flow data come from?
Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.